Boardroom Alpha
10-K primary document
AMRN · Annual Report (Form 10-K) · Filed March 2, 2026

Amarin Corp PLC10-K exhibit

amrn-ex21_1.htm
EX-21.1

 

EXHIBIT 21.1

Subsidiaries of the Registrant as of December 31, 2025

 

 

Name

Jurisdiction

Amarin Pharmaceuticals Ireland Limited

Ireland

Amarin Pharma, Inc.

United States

Ester Neurosciences Limited

Israel

Amarin Switzerland GmbH

Switzerland

Amarin Germany GmbH

Germany

Amarin France SAS

France

Amarin UK Limited

United Kingdom

Amarin Italy S.r.l

Italy

Amarin Switzerland GmbH Sucursal Espana

Spain

Amarin Switzerland GmbH Austrian branch

Austria

Amarin Belgium, branch of Amarin Switzerland GmbH

Belgium

Amarin Denmark, filial af Amarin Switzerland GmbH

Denmark

Amarin Switzerland GmbH, Suomen sivuliike

Finland

Amarin Switzerland GmbH Greek branch

Greece

Amarin Switzerland GmbH Dutch branch

Netherlands

Amarin Switzerland GmbH Norwegian branch

Norway

Amarin Switzerland GmbH, Sucursal em Portugal

Portugal

Amarin Switzerland GmbH Sweden filial

Sweden

 

 

 

 

 

 


Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer